Artificial Intelligence (AI) is transforming healthcare, promising significant improvements in diagnostic accuracy, operational efficiency, and patient outcomes. As AI technologies evolve, the importance of building large-scale, trustworthy, fair, and safe AI systems, coupled with innovative data-sharing methods like federated learning, becomes crucial. This workshop aims to explore the cutting-edge advancements in AI that are revolutionizing diagnostics, treatment, and management in the healthcare sector. With a focus on large foundational models, trustworthy AI, safety in AI, fairness AI applications, and federated learning, the workshop will provide insights into the latest technologies, ethical considerations, and practical challenges of implementing AI in healthcare.
Bioelectronics is a rapidly advancing field with profound implications for diagnostics and medical treatment. This symposium explores the latest breakthroughs in materials and devices driving the next generation of bioelectronic applications. Key topics include the development of bioelectronic devices, tissue–electronics interfaces, human-machine interaction, AI integration, and investigational tools for bioelectronic research. The symposium embraces an interdisciplinary approach, integrating insights from chemistry, materials science, electrical engineering, mechanical engineering, biomedical engineering, and biomedicine to foster revolutionary healthcare solutions.
Computational Fluid Dynamics (CFD) has emerged as a powerful tool in cardiovascular medicine, offering unprecedented insights into the complex hemodynamics of the human circulatory system. This symposium brings together leading researchers, clinicians, and engineers to explore the latest advancements and applications of CFD in cardiovascular research and clinical practice. We will delve into state-of-the-art modeling techniques, including patient-specific simulations and fluid-structure interactions, that are revolutionizing our understanding of cardiovascular physiology and pathology. The symposium will showcase how CFD is transforming diagnostics, treatment planning, and personalized medicine, from early disease detection to optimizing surgical interventions and drug delivery systems. By exploring the integration of CFD with experimental data and clinical trials, we aim to accelerate the development of more effective, targeted therapies for cardiovascular diseases. Join us in shaping the future of computational cardiovascular medicine and its potential to improve patient outcomes worldwide.
Although the discipline of BME has been established in Asia for decades, there is still a significant gap in commercial translational research between Asia and the United States, considering what the latter has achieved. The main reasons for this difference are as follow. First, the Pre-Med system in the United States has attracted many outstanding undergraduate students to the BME discipline. Second, Asia lacks medical manufacturers with major influence, which results in insufficient R&D capabilities and makes it more difficult for the medical field to attract investors than other consumer manufacturing fields.
Soft tissues include skin, muscles, cardiac tissue, tendons, ligaments, lymph, oral mucosa, and many other tissues. Biofabrication of soft tissues has inherent challenges compared to hard tissues like bone. Challenges are multi-dimensional which includes material challenges such as highly-elastic and compliant properties, dynamic mechanical properties, complex extra-cellular matrix composition, cellular diversity, vascularization, innervation, and higher susceptibility to immune responses. This symposium aims to bring leading researchers in the field to address the progress and challenges in the field of engineered soft tissues.
This special session will bring together leading researchers at the intersection of engineering and mechanobiology. It will explore the dynamic interplay between mechanical forces and biological processes, focusing on how cells sense, respond to, and are influenced by mechanical stimuli. Key topics will include cellular mechanotransduction, the role of mechanical forces in tissue development and disease, and the engineering of biomaterials that mimic or modulate cellular mechanical environments. Cutting-edge techniques for measuring and manipulating mechanical forces at the cellular level, as well as their applications in tissue engineering, regenerative medicine, and disease modeling will be highlighted. This session aims to foster interdisciplinary collaboration, offering a platform for engineers, biologists, and clinicians to exchange ideas and advance the field of mechanobiology using innovative engineering approaches.
Extracellular vesicles (EVs) are lipid membrane vesicles secreted by all cells in the body. These membrane vesicles, through their diverse cargo can reflect the state of their cell of origin, and can mediate intercellular communication, altering the functions and phenotypes of other cells. Increasingly, these membrane vesicles have been reported to be involved in many pathophysiological processes, thus providing opportunities for diagnostic and therapeutic applications. In recent years, there have been significant advances made in EV isolation and characterisation. With advances in biomedical engineering and nanotechnology, EV-mimetics and engineered EVs have also been developed as alternatives to native EVs for wide therapeutic applications. This symposium highlights the latest advances in EVs for diagnostic and therapeutic applications.
This symposium focuses on the innovative field of flexible and stretchable electronics for biomedical engineering. It will highlight breakthroughs in materials, fabrication techniques, and applications such as health monitoring, diagnostics, and therapeutics. The event aims to foster interdisciplinary collaboration and push the boundaries of biomedical engineering through advanced electronic technologies.
Transform your groundbreaking research into market-ready innovations!
Join our symposium to discover the secrets of turning academic discoveries into thriving MedTech startups. With speakers’ expertise ranging from regulatory and clinical affairs to their personal startup experiences, you can gain practical insights to launch your research innovations into impactful ventures.
Organized by MedTech Startups Professional Community (MSPC) and NUS MedTech, this symposium is designed for researchers to unlock the translational value of their research and navigate through new stages such as IP rights and product development in the process of commercialisation.
With a multidisciplinary lineup of speakers, you can acquire the skills and connections needed to make your research not just a published paper but a transformative market innovation.
Technological research and development are growing at a rapid phase in the Asia Pacific region. This is particularly true in the field of Biomedical Engineering, particularly with digitalization and artificial intelligence. The Asia Pacific region is estimated to be home to over 60% of the world’s population, with a significant proportion being aged 60 or older. Factors such as rising healthcare costs, an aging demographic, and an increase in chronic diseases contribute to MedTech growth. Currently, this region represents 18% of the approximately $660 billion global Medtech industry and is projected to be the fastest-growing region, with a 9% compound annual growth rate over the next five years. With the changing MedTech landscape, what changes need to be made in BME education to prepare students for the future. The symposia are oriented towards sharing the status and changes in Biomedical Engineering (BME) education, particularly on the structure of BME programs in the Asia Pacific Region to ensure relevancy and future-proof our students. These special symposia bring together some of the top BME educators from across the Asia Pacific regions to share and perhaps establish consensus to build future sustainable BME Education programs.
The symposium in ICBME 2024, “Multimodal Opto-Ultrasound Sensing and Imaging” aims to bring together a diverse group of top experts, researchers, and students to explore the field of optical, ultrasound, and/or combinational imaging technologies. The symposium will address the interdisciplinary topics across engineering, medicine, chemistry, and biology, with active discussions specifically on the latest technological innovations, preclinical and clinical applications, and the potential industrial impact of advanced multimodal optical and ultrasound imaging technologies. All participants will benefit from keynotes speeches and invited lectures on cutting-edge research and development in optical and ultrasound imaging, as well as interactive panel discussions to encourage collaboration and knowledge exchange. This symposium will feature the advancements and applications of these innovative imaging technologies. The Part I, “Pioneering Innovations in Biomedical Imaging Systems”, will delve into the latest advancements in multimodal imaging technologies, encompassing optical, ultrasound, and combinational imaging. The Part II, “Transformative Applications and Industrial Translation”, will discuss recent progress and practical applications of optical, ultrasound, and combinational imaging in both preclinical research and clinical settings and industrial efforts.
This special session will delve into the the application of nanotechnology to mechanobiology. It will explore how mechanical forces at the nanoscale influence biological processes, from molecular interactions within cells to the behavior of tissues. Topics will include nanoscale force measurement techniques, the role of nanomechanics in cellular signaling and development, and the engineering of nanoscale materials to control cellular functions. The session will highlight advances in atomic force microscopy, nanoparticle- and nanowire-based mechanotransduction, and the development of nanomaterials that mimic the mechanical environment of cells. By bridging nanotechnology and biology, this session will provide a unique platform for scientists and engineers to collaborate and push the boundaries of mechanobiology, offering new insights into how life functions at the smallest scales.
The rapid evolution of neurotechnology is transforming our ability to interface with the nervous system, offering unparalleled precision in neural modulation, monitoring, and therapeutic interventions. This symposium delves into the latest breakthroughs in materials and devices that are propelling the next generation of neurotechnological innovations. Key topics include the development of bioelectronic interfaces, organoid intelligence, and investigational tools for neuroscience research. Featuring insights from leading experts, this symposium underscores the interdisciplinary nature of neurotechnology research and its transformative potential for advancing biomedical engineering, neuroscience, biology, and medicine.
Artificial Intelligence for Medical Imaging” brings together innovators, clinicians, and researchers to explore the transformative potential of AI in medical imaging. As medical imaging generates an overwhelming amount of data, AI has emerged as a game-changer in extracting valuable insights, enhancing diagnosis, and improving patient outcomes. This symposium delves into the latest advancements in AI-powered image analysis, segmentation, and interpretation, as well as its applications in disease detection, personalized medicine, and image-guided interventions. Renowned experts will share their experiences, successes, and challenges in integrating AI into clinical workflows, addressing regulatory and ethical considerations, and fostering collaboration between academia, industry, and healthcare providers. Join us to discover the future of medical imaging, where AI-driven innovation meets clinical excellence, and together, we can revolutionize healthcare.
In vitro and ex vivo tumor models that recapitulate features of patient tumors are critical for supporting drug development, personalized oncology, and understanding mechanisms of tumor progression. This symposium will showcase the latest in vitro and ex vivo models that mimic cancer cells in their native tumor microenvironment, and the use of these models for drug testing and understanding the complexities of cancer.
Technical background: Dopamine Transporter Imaging (DAT imaging) is a method that uses molecular imaging technology to assess the distribution and activity of dopamine transporter (DAT) in the brain. DAT imaging is typically performed using Positron Emission Tomography (PET) or Single-Photon Emission Computed Tomography (SPECT). Radiolabeled ligands, such as [99mTc]-TRODAT-1 or [123I]-FP-CIT (for SPECT) and [18F]-PE2I (for PET), are able to specifically bind to DAT, allowing these techniques to visualize and quantify dopaminergic neuron activity. Clinical application: DAT imaging has become an important tool in the diagnosis and monitoring of Parkinson’s disease, dementia with Lewy bodies, and other neurodegenerative diseases that affect the dopamine system. Characteristics of these diseases often include changes in the mesolimbic dopamine system, and DAT imaging can help doctors detect early and track disease progression.
Join us for an exciting exploration into the transformative power of Generative AI in healthcare. This symposium will dive into revolutionary AI techniques enhancing medical imaging, early diagnosis, and personalized treatment. Discover how cutting-edge deep learning and synthetic data generation are overcoming traditional imaging limits, leading to more accurate healthcare solutions. Beyond imaging, we’ll showcase AI’s role in medical diagnostics, treatment planning, and microbiome research, highlighting innovative applications like GANs for dermatological imaging and Gaussian Copula Synthesizer for Atrial Fibrillation studies. Witness the fusion of AI and medical science as we uncover hidden microbial markers, navigate small dataset challenges, and elevate patient care. Don’t miss this opportunity to explore the future of healthcare through the lens of Generative AI!
The “Clinical Engineering and Regulatory Affairs” symposium is an essential platform that explores the critical relationship between clinical engineering and the regulatory frameworks that guide the development, deployment, and management of healthcare technologies. As medical devices and healthcare technologies become increasingly sophisticated and integral to patient care, the role of clinical engineers has expanded to ensure the effective operation of these technologies and their compliance with complex and ever-evolving regulatory standards. Key topics will include the lifecycle management of medical devices, focusing on maintaining compliance with international and local regulatory requirements. The symposium will also address the challenges posed by new technologies such as artificial intelligence, wearable devices, and telemedicine, reshaping the regulatory environment and demanding new approaches to compliance and safety. Attendees will gain valuable insights into the critical role of clinical engineers in ensuring that healthcare technologies meet rigorous safety and efficacy standards. Discussions will highlight the importance of interdisciplinary collaboration in effectively navigating the regulatory landscape.
This symposium focuses on the recent advancements in microfluidics, emphasizing how emergent technologies are revolutionizing the field. Examples of key technologies are additive manufacturing (AM) and artificial intelligence (AI). Additive manufacturing, or 3D printing, is enhancing microfluidic device fabrication by enabling the fabrication of complex, custom-designed channels and structures that were previously difficult to achieve. Unique sets of polymers and hydrogels applicable in 3D printing confer unprecedented functions to the devices. Artificial intelligence also plays a crucial role by optimizing the design and performance of microfluidic systems. AI-driven image analysis can push the boundaries of traditional microfluidic applications, such as advanced sensing and sorting. Altogether, these technologies are unlocking new possibilities in various fields in microfluidics, from personalized medicine to environmental monitoring. This symposium will showcase these innovations and explore their potential to fundamentally transform industries and research areas, with exciting future prospects for microfluidics.
Safe and effective weight-bearing and locomotion is wholly enabled by the body’s musculoskeletal system. This system consists of bones and joints, and the tissues of muscle, tendons, ligaments and cartilage. Given the mechanical nature of the musculoskeletal system, the clinical approach to solving problems in this area rely heavily on mechanics. Orthopaedic biomechanics is an established field in bioengineering and biomedical engineering, and arguably a key originator in the initial collaboration of medicine and engineering. From developing fracture fixation methods and instrumentation, joint repair and replacement technology, tissue engineering and mechanobiology, and even the study of diseases of the bones and joints, the research and practice domains of orthopaedic biomechanics has considerable breadth along with deep impacts. In this symposium we present several examples of cutting edge research in orthopaedic biomechanics being applied to the prevention, treatment, repair, and management of orthopaedic clinical problems.
Red blood cells (RBCs) play a vital role in oxygen transport and overall health. A deeper understanding of their mechanics—how they function and interact at a cellular and molecular levels—can provide valuable insights into various physiological and pathological conditions. We are excited to invite you to the Red Blood Cell Mechanics for Diseases & Diagnosis symposium, a pivotal event designed to foster interdisciplinary dialogue and collaboration among researchers and clinicians at the forefront of red blood cell science.
We are organizing this symposium with the following objectives: 1) to present and discuss the latest research findings related to red blood cell mechanics, including insights into cell structure, function, and the mechanical properties of erythrocytes; 2) to bridge the gap between cutting-edge research and clinical practice, highlighting innovative diagnostic tools, therapeutic strategies, and treatment advancements that are emerging from recent studies; 3) to create a dynamic forum for researchers, clinicians, and healthcare professionals to exchange ideas, share insights, and foster collaborations; and 4) to showcase groundbreaking studies and novel applications, with the aim of inspiring new research directions and clinical approaches in red blood cell science.
Wearable technologies have evolved into a transformative force in healthcare, enabling continuous monitoring and personalized interventions. This symposium will delve into these cutting-edge advancements and their significant impact on human health. Experts from diverse fields will discuss innovations in sensor technology, data analytics, and human-computer interaction, focusing on applications in real-time health monitoring, disease prevention, and personalized medicine. Key topics include the innovation in biomaterials, the development of non-invasive biosensors, and the integration of artificial intelligence for predictive analytics. The symposium aims to foster interdisciplinary collaboration, showcase emerging trends, and envision the future of wearable healthcare technologies.
APBEC Symposium is a special symposium endorsed by the Asia Pacific Biomedical Engineering Consortium (APBEC). APBEC is a collaborative platform established in Feb. 2024, aiming to foster interaction and promote collaborative research and education in the field of biomedical engineering among scholars and students in six partnership institutions in Asia-Pacific Rim, incl., National University of Singapore, National Taiwan University, Seoul National University, Tsinghua University, The University of Tokyo, and The Hong Kong University of Science and Technology. We hope this special symposium will highlight some exciting and innovative biomedical engineering research activities undertaken by APBEC members and provide opportunities for interactions with ICBME participants.
Artificial Intelligence (AI) is transforming healthcare, promising significant improvements in diagnostic accuracy, operational efficiency, and patient outcomes. As AI technologies evolve, the importance of building large-scale, trustworthy, fair, and safe AI systems, coupled with innovative data-sharing methods like federated learning, becomes crucial. This workshop aims to explore the cutting-edge advancements in AI that are revolutionizing diagnostics, treatment, and management in the healthcare sector. With a focus on large foundational models, trustworthy AI, safety in AI, fairness AI applications, and federated learning, the workshop will provide insights into the latest technologies, ethical considerations, and practical challenges of implementing AI in healthcare.
Bioelectronics is a rapidly advancing field with profound implications for diagnostics and medical treatment. This symposium explores the latest breakthroughs in materials and devices driving the next generation of bioelectronic applications. Key topics include the development of bioelectronic devices, tissue–electronics interfaces, human-machine interaction, AI integration, and investigational tools for bioelectronic research. The symposium embraces an interdisciplinary approach, integrating insights from chemistry, materials science, electrical engineering, mechanical engineering, biomedical engineering, and biomedicine to foster revolutionary healthcare solutions.
Computational Fluid Dynamics (CFD) has emerged as a powerful tool in cardiovascular medicine, offering unprecedented insights into the complex hemodynamics of the human circulatory system. This symposium brings together leading researchers, clinicians, and engineers to explore the latest advancements and applications of CFD in cardiovascular research and clinical practice. We will delve into state-of-the-art modeling techniques, including patient-specific simulations and fluid-structure interactions, that are revolutionizing our understanding of cardiovascular physiology and pathology. The symposium will showcase how CFD is transforming diagnostics, treatment planning, and personalized medicine, from early disease detection to optimizing surgical interventions and drug delivery systems. By exploring the integration of CFD with experimental data and clinical trials, we aim to accelerate the development of more effective, targeted therapies for cardiovascular diseases. Join us in shaping the future of computational cardiovascular medicine and its potential to improve patient outcomes worldwide.
Although the discipline of BME has been established in Asia for decades, there is still a significant gap in commercial translational research between Asia and the United States, considering what the latter has achieved. The main reasons for this difference are as follow. First, the Pre-Med system in the United States has attracted many outstanding undergraduate students to the BME discipline. Second, Asia lacks medical manufacturers with major influence, which results in insufficient R&D capabilities and makes it more difficult for the medical field to attract investors than other consumer manufacturing fields.
Soft tissues include skin, muscles, cardiac tissue, tendons, ligaments, lymph, oral mucosa, and many other tissues. Biofabrication of soft tissues has inherent challenges compared to hard tissues like bone. Challenges are multi-dimensional which includes material challenges such as highly-elastic and compliant properties, dynamic mechanical properties, complex extra-cellular matrix composition, cellular diversity, vascularization, innervation, and higher susceptibility to immune responses. This symposium aims to bring leading researchers in the field to address the progress and challenges in the field of engineered soft tissues.
This special session will bring together leading researchers at the intersection of engineering and mechanobiology. It will explore the dynamic interplay between mechanical forces and biological processes, focusing on how cells sense, respond to, and are influenced by mechanical stimuli. Key topics will include cellular mechanotransduction, the role of mechanical forces in tissue development and disease, and the engineering of biomaterials that mimic or modulate cellular mechanical environments. Cutting-edge techniques for measuring and manipulating mechanical forces at the cellular level, as well as their applications in tissue engineering, regenerative medicine, and disease modeling will be highlighted. This session aims to foster interdisciplinary collaboration, offering a platform for engineers, biologists, and clinicians to exchange ideas and advance the field of mechanobiology using innovative engineering approaches.
Extracellular vesicles (EVs) are lipid membrane vesicles secreted by all cells in the body. These membrane vesicles, through their diverse cargo can reflect the state of their cell of origin, and can mediate intercellular communication, altering the functions and phenotypes of other cells. Increasingly, these membrane vesicles have been reported to be involved in many pathophysiological processes, thus providing opportunities for diagnostic and therapeutic applications. In recent years, there have been significant advances made in EV isolation and characterisation. With advances in biomedical engineering and nanotechnology, EV-mimetics and engineered EVs have also been developed as alternatives to native EVs for wide therapeutic applications. This symposium highlights the latest advances in EVs for diagnostic and therapeutic applications.
This symposium focuses on the innovative field of flexible and stretchable electronics for biomedical engineering. It will highlight breakthroughs in materials, fabrication techniques, and applications such as health monitoring, diagnostics, and therapeutics. The event aims to foster interdisciplinary collaboration and push the boundaries of biomedical engineering through advanced electronic technologies.
Transform your groundbreaking research into market-ready innovations!
Join our symposium to discover the secrets of turning academic discoveries into thriving MedTech startups. With speakers’ expertise ranging from regulatory and clinical affairs to their personal startup experiences, you can gain practical insights to launch your research innovations into impactful ventures.
Organized by MedTech Startups Professional Community (MSPC) and NUS MedTech, this symposium is designed for researchers to unlock the translational value of their research and navigate through new stages such as IP rights and product development in the process of commercialisation.
With a multidisciplinary lineup of speakers, you can acquire the skills and connections needed to make your research not just a published paper but a transformative market innovation.
Technological research and development are growing at a rapid phase in the Asia Pacific region. This is particularly true in the field of Biomedical Engineering, particularly with digitalization and artificial intelligence. The Asia Pacific region is estimated to be home to over 60% of the world’s population, with a significant proportion being aged 60 or older. Factors such as rising healthcare costs, an aging demographic, and an increase in chronic diseases contribute to MedTech growth. Currently, this region represents 18% of the approximately $660 billion global Medtech industry and is projected to be the fastest-growing region, with a 9% compound annual growth rate over the next five years. With the changing MedTech landscape, what changes need to be made in BME education to prepare students for the future. The symposia are oriented towards sharing the status and changes in Biomedical Engineering (BME) education, particularly on the structure of BME programs in the Asia Pacific Region to ensure relevancy and future-proof our students. These special symposia bring together some of the top BME educators from across the Asia Pacific regions to share and perhaps establish consensus to build future sustainable BME Education programs.
The symposium in ICBME 2024, “Multimodal Opto-Ultrasound Sensing and Imaging” aims to bring together a diverse group of top experts, researchers, and students to explore the field of optical, ultrasound, and/or combinational imaging technologies. The symposium will address the interdisciplinary topics across engineering, medicine, chemistry, and biology, with active discussions specifically on the latest technological innovations, preclinical and clinical applications, and the potential industrial impact of advanced multimodal optical and ultrasound imaging technologies. All participants will benefit from keynotes speeches and invited lectures on cutting-edge research and development in optical and ultrasound imaging, as well as interactive panel discussions to encourage collaboration and knowledge exchange. This symposium will feature the advancements and applications of these innovative imaging technologies. The Part I, “Pioneering Innovations in Biomedical Imaging Systems”, will delve into the latest advancements in multimodal imaging technologies, encompassing optical, ultrasound, and combinational imaging. The Part II, “Transformative Applications and Industrial Translation”, will discuss recent progress and practical applications of optical, ultrasound, and combinational imaging in both preclinical research and clinical settings and industrial efforts.
This special session will delve into the the application of nanotechnology to mechanobiology. It will explore how mechanical forces at the nanoscale influence biological processes, from molecular interactions within cells to the behavior of tissues. Topics will include nanoscale force measurement techniques, the role of nanomechanics in cellular signaling and development, and the engineering of nanoscale materials to control cellular functions. The session will highlight advances in atomic force microscopy, nanoparticle- and nanowire-based mechanotransduction, and the development of nanomaterials that mimic the mechanical environment of cells. By bridging nanotechnology and biology, this session will provide a unique platform for scientists and engineers to collaborate and push the boundaries of mechanobiology, offering new insights into how life functions at the smallest scales.
The rapid evolution of neurotechnology is transforming our ability to interface with the nervous system, offering unparalleled precision in neural modulation, monitoring, and therapeutic interventions. This symposium delves into the latest breakthroughs in materials and devices that are propelling the next generation of neurotechnological innovations. Key topics include the development of bioelectronic interfaces, organoid intelligence, and investigational tools for neuroscience research. Featuring insights from leading experts, this symposium underscores the interdisciplinary nature of neurotechnology research and its transformative potential for advancing biomedical engineering, neuroscience, biology, and medicine.
Artificial Intelligence for Medical Imaging” brings together innovators, clinicians, and researchers to explore the transformative potential of AI in medical imaging. As medical imaging generates an overwhelming amount of data, AI has emerged as a game-changer in extracting valuable insights, enhancing diagnosis, and improving patient outcomes. This symposium delves into the latest advancements in AI-powered image analysis, segmentation, and interpretation, as well as its applications in disease detection, personalized medicine, and image-guided interventions. Renowned experts will share their experiences, successes, and challenges in integrating AI into clinical workflows, addressing regulatory and ethical considerations, and fostering collaboration between academia, industry, and healthcare providers. Join us to discover the future of medical imaging, where AI-driven innovation meets clinical excellence, and together, we can revolutionize healthcare.
In vitro and ex vivo tumor models that recapitulate features of patient tumors are critical for supporting drug development, personalized oncology, and understanding mechanisms of tumor progression. This symposium will showcase the latest in vitro and ex vivo models that mimic cancer cells in their native tumor microenvironment, and the use of these models for drug testing and understanding the complexities of cancer.
Technical background: Dopamine Transporter Imaging (DAT imaging) is a method that uses molecular imaging technology to assess the distribution and activity of dopamine transporter (DAT) in the brain. DAT imaging is typically performed using Positron Emission Tomography (PET) or Single-Photon Emission Computed Tomography (SPECT). Radiolabeled ligands, such as [99mTc]-TRODAT-1 or [123I]-FP-CIT (for SPECT) and [18F]-PE2I (for PET), are able to specifically bind to DAT, allowing these techniques to visualize and quantify dopaminergic neuron activity. Clinical application: DAT imaging has become an important tool in the diagnosis and monitoring of Parkinson’s disease, dementia with Lewy bodies, and other neurodegenerative diseases that affect the dopamine system. Characteristics of these diseases often include changes in the mesolimbic dopamine system, and DAT imaging can help doctors detect early and track disease progression.
Join us for an exciting exploration into the transformative power of Generative AI in healthcare. This symposium will dive into revolutionary AI techniques enhancing medical imaging, early diagnosis, and personalized treatment. Discover how cutting-edge deep learning and synthetic data generation are overcoming traditional imaging limits, leading to more accurate healthcare solutions. Beyond imaging, we’ll showcase AI’s role in medical diagnostics, treatment planning, and microbiome research, highlighting innovative applications like GANs for dermatological imaging and Gaussian Copula Synthesizer for Atrial Fibrillation studies. Witness the fusion of AI and medical science as we uncover hidden microbial markers, navigate small dataset challenges, and elevate patient care. Don’t miss this opportunity to explore the future of healthcare through the lens of Generative AI!
The “Clinical Engineering and Regulatory Affairs” symposium is an essential platform that explores the critical relationship between clinical engineering and the regulatory frameworks that guide the development, deployment, and management of healthcare technologies. As medical devices and healthcare technologies become increasingly sophisticated and integral to patient care, the role of clinical engineers has expanded to ensure the effective operation of these technologies and their compliance with complex and ever-evolving regulatory standards. Key topics will include the lifecycle management of medical devices, focusing on maintaining compliance with international and local regulatory requirements. The symposium will also address the challenges posed by new technologies such as artificial intelligence, wearable devices, and telemedicine, reshaping the regulatory environment and demanding new approaches to compliance and safety. Attendees will gain valuable insights into the critical role of clinical engineers in ensuring that healthcare technologies meet rigorous safety and efficacy standards. Discussions will highlight the importance of interdisciplinary collaboration in effectively navigating the regulatory landscape.
Safe and effective weight-bearing and locomotion is wholly enabled by the body’s musculoskeletal system. This system consists of bones and joints, and the tissues of muscle, tendons, ligaments and cartilage. Given the mechanical nature of the musculoskeletal system, the clinical approach to solving problems in this area rely heavily on mechanics. Orthopaedic biomechanics is an established field in bioengineering and biomedical engineering, and arguably a key originator in the initial collaboration of medicine and engineering. From developing fracture fixation methods and instrumentation, joint repair and replacement technology, tissue engineering and mechanobiology, and even the study of diseases of the bones and joints, the research and practice domains of orthopaedic biomechanics has considerable breadth along with deep impacts. In this symposium we present several examples of cutting edge research in orthopaedic biomechanics being applied to the prevention, treatment, repair, and management of orthopaedic clinical problems.
Red blood cells (RBCs) play a vital role in oxygen transport and overall health. A deeper understanding of their mechanics—how they function and interact at a cellular and molecular levels—can provide valuable insights into various physiological and pathological conditions. We are excited to invite you to the Red Blood Cell Mechanics for Diseases & Diagnosis symposium, a pivotal event designed to foster interdisciplinary dialogue and collaboration among researchers and clinicians at the forefront of red blood cell science.
We are organizing this symposium with the following objectives: 1) to present and discuss the latest research findings related to red blood cell mechanics, including insights into cell structure, function, and the mechanical properties of erythrocytes; 2) to bridge the gap between cutting-edge research and clinical practice, highlighting innovative diagnostic tools, therapeutic strategies, and treatment advancements that are emerging from recent studies; 3) to create a dynamic forum for researchers, clinicians, and healthcare professionals to exchange ideas, share insights, and foster collaborations; and 4) to showcase groundbreaking studies and novel applications, with the aim of inspiring new research directions and clinical approaches in red blood cell science.
Wearable technologies have evolved into a transformative force in healthcare, enabling continuous monitoring and personalized interventions. This symposium will delve into these cutting-edge advancements and their significant impact on human health. Experts from diverse fields will discuss innovations in sensor technology, data analytics, and human-computer interaction, focusing on applications in real-time health monitoring, disease prevention, and personalized medicine. Key topics include the innovation in biomaterials, the development of non-invasive biosensors, and the integration of artificial intelligence for predictive analytics. The symposium aims to foster interdisciplinary collaboration, showcase emerging trends, and envision the future of wearable healthcare technologies.
APBEC Symposium is a special symposium endorsed by the Asia Pacific Biomedical Engineering Consortium (APBEC). APBEC is a collaborative platform established in Feb. 2024, aiming to foster interaction and promote collaborative research and education in the field of biomedical engineering among scholars and students in six partnership institutions in Asia-Pacific Rim, incl., National University of Singapore, National Taiwan University, Seoul National University, Tsinghua University, The University of Tokyo, and The Hong Kong University of Science and Technology. We hope this special symposium will highlight some exciting and innovative biomedical engineering research activities undertaken by APBEC members and provide opportunities for interactions with ICBME participants.
Name | Date |
---|---|
Special Symposium Proposal Submission | 1 May to 31 July 2024 |
Notification of SS Acceptance | By 31 August 2024 |
Speakers’ Abstract Submission | 15 August to 8 September 2024 |
Author Registration Deadline | 31 October 2024 |